Conference to Clinic Roundtable: Applying the Latest Data Developments for Therapies Targeting TROP-2 and TIGIT in Lung Cancer

Gain expert insights into patients with lung cancer who will mostly likely benefit from novel therapies targeting TROP-2 and TIGIT based on recent data to enhance clinical outcomes through a certified on-demand webcast, expert-authored ClinicalThought commentary, and downloadable slides.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.